Health Canada has announced a recall of certain lot numbers of the anti-seizure drug Lamotrigine
manufacturered by Sanis Health and Mylan Pharmaceuticals due to product quality issues.
As of May 27, Health Canada has not received any reports of adverse reactions and patients are
advised not to discontinue their treatment unless directed by their healthcare professional.
For More Information About Epilepsy and Antiseizure Medication. Please Visit www.epilepsyns.com